title: Transient improvement of severe pain from fibrous dysplasia of bone with denosumab treatment.
authors: INSERM UMR 1033, department of rheumatology, Université de Lyon, Hospices Civils de Lyon, France. Electronic address: johanna.be@hotmail.fr.
authors: Johanna
authors: J
authors: Benhamou
authors: INSERM UMR 1033, department of rheumatology, Université de Lyon, Hospices Civils de Lyon, France.
authors: Deborah
authors: D
authors: Gensburger
authors: INSERM UMR 1033, department of rheumatology, Université de Lyon, Hospices Civils de Lyon, France.
authors: Roland
authors: R
authors: Chapurlat
mesh_terms: D000700:Analgesics / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D015415:Biomarkers / Q000097:blood; D024042:Collagen Type I / Q000097:blood; D000069448:Denosumab; D005357:Fibrous Dysplasia of Bone / Q000097:blood / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy*; D010455:Peptides / Q000097:blood; D053245:RANK Ligand / Q000037:antagonists & inhibitors; D017211:Treatment Failure
chemical_list: D000700:Analgesics; D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; D024042:Collagen Type I; D010455:Peptides; D053245:RANK Ligand; C052929:collagen type I trimeric cross-linked peptide; D000069448:Denosumab
keywords: Bisphosphonate; Denosumab; Fibrous dysplasia of bone; RANKL